These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29706441)

  • 1. Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke.
    Oguro H; Mitaki S; Takayoshi H; Abe S; Onoda K; Yamaguchi S
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2175-2181. PubMed ID: 29706441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ozagrel for Patients With Noncardioembolic Ischemic Stroke: A Propensity Score-Matched Analysis.
    Wada T; Yasunaga H; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2828-2837. PubMed ID: 27567296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
    Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
    Shinohara Y; Saito I; Kobayashi S; Uchiyama S
    Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of effect of edaravone on ischemic stroke.
    Ishibashi A; Yoshitake Y; Adachi H
    Kurume Med J; 2013; 60(2):53-7. PubMed ID: 24291782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Argatroban Treatment in Patients With Atherothrombotic Stroke: Observational Nationwide Study in Japan.
    Wada T; Yasunaga H; Horiguchi H; Matsubara T; Fushimi K; Nakajima S; Yahagi N
    Stroke; 2016 Feb; 47(2):471-6. PubMed ID: 26670085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical effect of combination therapy with edaravone and sodium ozagrel for acute cerebral infarction].
    Takabatake Y; Uno E; Wakamatsu K; Yamazaki N; Hashimoto N; Tsuchiya Y
    No To Shinkei; 2003 Jul; 55(7):589-93. PubMed ID: 12910992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and long-term outcomes of argatroban use in patients with acute noncardioembolic stroke.
    Chen S; Cai D; Huang P; Liu J; Lai Y; He J; Zhou L; Sun H
    Clin Neurol Neurosurg; 2020 Nov; 198():106233. PubMed ID: 32977247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
    Barreto AD; Ford GA; Shen L; Pedroza C; Tyson J; Cai C; Rahbar MH; Grotta JC;
    Stroke; 2017 Jun; 48(6):1608-1616. PubMed ID: 28507269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
    Kumagai N; Origasa H; Nagao T; Takekawa H; Okuhara Y; Yamaguchi T
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):792-8. PubMed ID: 22633681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): Rationale and design.
    Yang Y; Zhou Z; Pan Y; Chen H; Wang Y;
    Am Heart J; 2020 Jul; 225():38-43. PubMed ID: 32485328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of therapies for acute ischemic stroke in China: a network meta-analysis of 13289 patients from 145 randomized controlled trials.
    Yang B; Shi J; Chen X; Ma B; Sun H
    PLoS One; 2014; 9(2):e88440. PubMed ID: 24551100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of smoking on outcomes after acute atherothrombotic stroke in Japanese men.
    Kumagai N; Okuhara Y; Iiyama T; Fujimoto Y; Takekawa H; Origasa H; Kawanishi Y; Yamaguchi T
    J Neurol Sci; 2013 Dec; 335(1-2):164-8. PubMed ID: 24112970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban plus aspirin versus aspirin in acute ischemic stroke.
    Chen L; Cao S; Yang J
    Neurol Res; 2018 Oct; 40(10):862-867. PubMed ID: 30052164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy.
    Urabe T; Tanaka R; Noda K; Mizuno Y
    J Thromb Thrombolysis; 2002 Jun; 13(3):155-60. PubMed ID: 12355032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of the neuroprotective agent edaravone for noncardioembolic cerebral infarction.
    Shinohara Y; Inoue S
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):668-74. PubMed ID: 22622391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke.
    Hosomi N; Naya T; Kohno M; Kobayashi S; Koziol JA;
    J Neurol; 2007 May; 254(5):605-12. PubMed ID: 17417744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cilostazol in the treatment of acute ischemic stroke in the lenticulostriate artery territory.
    Kondo R; Matsumoto Y; Furui E; Itabashi R; Sato S; Yazawa Y; Shimizu H; Fujiwara S; Takahashi A; Tominaga T
    Eur Neurol; 2013; 69(2):122-8. PubMed ID: 23207729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin inhibition in the acute phase of ischaemic stroke using argatroban.
    Kario K; Kodama K; Koide M; Matsuo T
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):423-7. PubMed ID: 8589208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients.
    Liu S; Liu P; Wang P; Zhang F; Wang L; Wang Y; Lu H; Ma X
    Med Sci Monit; 2020 Jul; 26():e924593. PubMed ID: 32667287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.